NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
1.260
-0.030 (-2.33%)
At close: Oct 16, 2026, 4:00 PM EDT
1.280
+0.020 (1.59%)
After-hours: Oct 16, 2026, 4:29 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $146.16 million as of October 16, 2026. It is the 22,599th most valuable company in the world and the 3,805th biggest in the United States. Its market cap has decreased by 79.31% in one year.
Market Cap
146.16M
Enterprise Value
-40.23M
1-Year Change
-79.31%
Global Rank
Country Rank
#3,805 United States
Category
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $146.16M, an increase of 5.88%. That is a compound annual growth rate of 0.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 146.16M | -68.15% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compass Therapeutics | 158.30M |
| Veraxa Biotech AG | 156.96M |
| MediWound | 153.76M |
| Adagene | 153.76M |
| Jyong Biotech | 152.18M |
| Protara Therapeutics | 146.56M |
| Canton Strategic Holdings | 146.22M |
| Nkarta | 145.40M |